TFRC promotes ferroptosis to suppress breast cancer bone metastasis via the activation of HIF 1 pathway
TFRC inhibits bone metastasis in breast cancer by promoting ferroptosis via HIF 1 activation, highlighting its potential as a therapeutic target.